Gregory L Cowan is Director of RVL Pharmaceuticals plc. Currently has a direct ownership of 90,055 shares of RVLP, which is worth approximately $0. The most recent transaction as insider was on Jul 05, 2023, when has been sold 40,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90.1K
0% 3M change
0% 12M change
Total Value Held $0

GREGORY L COWAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 05 2023
BUY
Grant, award, or other acquisition
-
40,000 Added 30.76%
90,055 Ordinary Shares
Aug 27 2021
SELL
Payment of exercise price or tax liability
$18,225 $3.31 p/Share
5,506 Reduced 9.91%
50,055 Ordinary Shares
Jun 18 2021
SELL
Payment of exercise price or tax liability
$53,708 $2.89 p/Share
18,584 Reduced 25.06%
55,561 Ordinary Shares
Jan 24 2021
SELL
Payment of exercise price or tax liability
$24,552 $4.46 p/Share
5,505 Reduced 6.91%
74,145 Ordinary Shares
GLC

Gregory L Cowan

Director
Bridgewater, NJ

Track Institutional and Insider Activities on RVLP

Follow RVL Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVLP shares.

Notify only if

Insider Trading

Get notified when an Rvl Pharmaceuticals PLC insider buys or sells RVLP shares.

Notify only if

News

Receive news related to RVL Pharmaceuticals plc

Track Activities on RVLP